Texas Covered Clinical Leadership Forum
The Texas Covered Clinical Leadership Forum is a redesigned, invitation-only working session for clinical leaders across Texas health plans, including medical, pharmacy, dental, vision, and behavioral health.
The forum focuses on peer discussion, practical problem-solving, and collaboration around shared clinical challenges. The format includes a structured day with clinical and educational sessions and time reserved for health plan–only discussion.
đź”’ Attendance is restricted to health plan clinical leaders and approved event sponsors.
Scroll down for agenda
Stephen F. Austin, Capitol Ballroom B
701 Congress Ave., Austin, TX
Apr 28, 2026
9:15 am - 3:30 pm
Sponsored by
Agenda
9:15 am
Opening Remarks + Announcements
9:30 am
High-Value Care Starts Here: Integrating Lifestyle Medicine into the Modern Care Model
Chronic disease is the defining challenge of modern healthcare, and managing it with medications alone is neither clinically sufficient nor financially sustainable. This keynote makes the case for lifestyle medicine as the foundation of high-value care, showing how health plans and clinical leaders can move beyond symptom management to root-cause interventions that reduce utilization, improve outcomes, and align with emerging federal care models. Drawing on real-world implementation data and the latest in reimbursement innovation, this session offers a practical roadmap for integrating lifestyle medicine into care delivery not as a wellness add-on, but as a core clinical strategy.
Speaker: Padmaja Patel, MD, FACLM, DipABLM, CPE
10:15 am
A Roadmap to Prior Authorization Modernization: Strategic Approaches Across Medicare, Medicaid, and Commercial Lines
As health plans face mounting pressure to modernize prior authorization across all lines of business, understanding the distinct compliance requirements, operational challenges, and strategic opportunities for each market segment has never been more critical. This session provides a comprehensive roadmap for how leading health plans are approaching prior authorization modernization across Medicare, Medicaid, and commercial populations, from regulatory compliance to operational excellence.
Speaker: Michael Lunzer, CEO, Itiliti Health
11:00 am
Current Treatment of CLL with Focus on Future Therapies
This session provides a comparative look at BTK inhibitors in CLL, with a focus on zanubrutinib. Drawing from Phase 2 and 3 trials, the discussion will highlight recent updates on safety, efficacy, and patient tolerance trends across the BTKi class. On the horizon, next-generation BCL2 inhibitors and BTK CDACs hope to offer deeper responses and extended survival in mono/combo treatment approaches in both 1L and R/R settings. Attendees will gain insight into clinical and economic factors shaping oncology treatment decisions today.
Speaker: Kirk S. Culotta, PharmD, Senior Director, Medical Value & Outcomes, BeOne Medicines USA, Inc.
11:45 am
Improving Birth Outcomes Nationwide: Pomelo’s Virtual Care Model and Peer-Reviewed Impact
12:10 pm
Shield Healthcare Diabetes Management Pilot: An Endocrinologist-Led CGM Virtual Diabetes Program
Shield Healthcare is expanding beyond CGM fulfillment to offer plans an endocrinology-led virtual diabetes program that delivers measurable value for their high-risk, insulin-treated members. Shield HealthCare deploys CGM and our team of diabetes educators monitors and reviews CGM data based on clinical need, proactively reaches out to high or rising risk members, supports diabetes care gap closure, and delivers protocol-driven therapy. The result is improved glycemic control, fewer avoidable acute events, and lower diabetes-related spend with stronger quality performance.
Speaker: Eric Morrow, Director of Business Development, Shield HealthCare
12:30 pm
Lunch + Peer Networking
1-3:30 pm
Closed Door Collaborative Session: Improving Health Plan and Primary Care Alignment in Texas
This collaborative work session will bring together TAHP clinical leaders and primary care stakeholders to discuss practical ways to improve how health plans and physician practices collaborate in Texas. The focus is on identifying realistic opportunities to improve communication, streamline workflows, and reduce unnecessary administrative burden while maintaining appropriate clinical standards, quality, and accountability. The goal is to leave with a small set of pragmatic ideas for continued collaboration and operational improvement.
- Facilitator: Ken Janda, Principal of Wild Blue Health Solutions
- Participants: Texas Primary Care Consortium (TPCC) and Key Stakeholders
Speakers
Padmaja Patel, MD
President, American College of Lifestyle Medicine
Padmaja Patel, MD, FACLM, DipABLM, CPE, is a board-certified internist and nationally recognized physician leader specializing in Lifestyle Medicine, Whole-Person Health, and value-based care transformation.
She currently serves as President of the American College of Lifestyle Medicine (ACLM) and Chief Medical Officer of Nudj Health, an ACLM-certified Lifestyle Treatment Program focused on scalable, evidence-based lifestyle interventions.
Dr. Patel holds multiple leadership and advisory roles at the intersection of clinical care, quality measurement, and health policy. She is President of the Midland Quality Alliance, a physician-led ACO-REACH organization in Midland, Texas, and serves as a consultant to the Texas Medical Association’s Alternative Payment Model Committee.
At the national level, she has served on the National Quality Forum’s Healthcare Professional Advisory Council, the Partnership for Quality Measurement, and the Whole Person Health workgroup of the Primary Care Collaborative. She is also the founding Chair of ACLM’s Clinical Practice and Quality Committee and a member of the Texas Nutrition Advisory Committee, appointed by the Governor of Texas.
A pioneer in the field of Lifestyle Medicine, Dr. Patel has designed and implemented innovative care delivery models that integrate lifestyle medicine as a therapeutic intervention within health systems. Her work includes developing an office-based intensive cardiac rehabilitation program, serving as Medical Director of the Lifestyle Medicine Center at Midland Health, and leading intensive therapeutic lifestyle change (ITLC) programs that have demonstrated chronic disease remission in both in-person and virtual settings.
She has also served as Lifestyle Medicine Medical Director at Wellvana, a national value-based care organization, and as Vice President of the World Lifestyle Medicine Organization.
Dr. Patel is a leading advocate for embedding lifestyle medicine across the continuum of care, including primary care, specialty care, employee health, and population health, with a focus on improving outcomes while reducing the total cost of care. Her work integrating lifestyle medicine into employee health programs has resulted in meaningful cost savings and improved health outcomes, reinforcing lifestyle medicine as a cornerstone of high-value care.
In recognition of her contributions, Dr. Patel has been named a Fellow of the American College of Lifestyle Medicine and received the 2023 AMWA Inspire Award, honoring her leadership, advocacy, and service to the health care community.
She is a Certified Lifestyle Medicine Intensivist, a designation awarded to clinicians who have demonstrated expertise in using lifestyle medicine to prevent, treat, and reverse chronic disease at individual and population levels. Dr. Patel is also a co-founder of Healthy City, a nonprofit organization dedicated to advancing community awareness of plant-based nutrition and lifestyle medicine.
I can also tighten this into a cleaner speaker bio version if you want something more polished for an agenda, website, or email.
×
Kirk Culotta, PharmD
Senior Director, Medical Value & Outcomes, BeOne Medicines
Over the past 25+ years in oncology, Kirk Culotta has spent the majority of his time at UT MD Anderson Cancer Center where he started as a fellow in Clinical Pharmacology & Drug Development then continued as a clinical pharmacist for the Clinical & Translational Research Center and ended up as an Assistant Professor in the Division of Cancer Medicine and Center for Targeted Therapy. His roles included Scientific Director of the Pharmaceutical Development Center, PK/PD Director of the Southwest Early Clinical Trials Consortium, Associate Faculty in the Experimental Therapeutics Academic Program at UT Graduate School of Biomedical Sciences, and Program Director for the Pharmacy Research Fellowship in Oncology. He has been co-investigator or collaborator on more than 10 NCI/NIH grants and 65 translational research trials plus co-authored more than 60 publications in 20 international peer-reviewed journals presented at 15 national congresses. Over the past 10 years in his managed care industry role, he has launched 50+ indications across 30+ tumor types utilizing both biologic and small molecule technologies with roles and responsibilities having largely included establishing and maintaining scientifically credible peer-to-peer scientific relationships with national and regional payers and population health decision makers, communicating and presenting clinical and health economics/outcomes research (HEOR) data, and assisting with real world evidence, including collaborating with key external stakeholders, and supporting development of key endpoints or outcomes. In addition, he was the national co-lead for the addition of more than 40 treatment regimens to payer oncology pathways across 20+ tumors over the past 5 years.
×
Michael Lunzer
Founder and CEO, Itiliti Health
Michael Lunzer is the Founder and CEO of Itiliti Health, Inc., where he drives innovation in healthcare by streamlining and automating prior authorization. A seasoned entrepreneur, Michael co-founded the first-ever technology-based vendor management system for the staffing industry, which processed $2 billion annually by 2005. He also co-founded Warm Health, a virtual care management platform for payers, which was later acquired by Change Healthcare. With a career focused on solving inefficiencies through technology, Michael continues to lead transformative change in healthcare, making him a sought-after speaker on industry innovation and optimization.
×
Eric Morrow
Director of Business Development, Shield HealthCare
For more than 30 years, Eric Morrow has dedicated his career to helping people live safely and with dignity at home. He began in the direct-to-consumer space long before it was mainstream, learning firsthand how the right product, delivered with compassion and reliability, can change daily life for families. Over the years, he has led high-performing teams and built innovative clinical programs focused on incontinence care, fall prevention, and enteral nutrition support, always keeping the person—not just the condition—at the center. Colleagues know him as a steady, thoughtful leader who listens deeply, connects across disciplines, and turns complex clinical needs into practical solutions that truly support patients and caregivers.
×